PTEN loss has been associated with reduced antigen presentation, impaired T-cell infiltration, and resistance to immune checkpoint blockade—suggesting a dual role for PTEN in promoting both tumor growth and immune evasion [71,72,73,74]. This evidence concerns the gene PTEN and neoplasm.